Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Siemens Healthcare and Laboratory Corporation of America Holdings have entered into a non-exclusive agreement to discuss future possibilities to co-develop new clinical diagnostic tests in the areas of companion diagnostics, metabolic syndrome, oncology and diabetes.
Subscribe to our email newsletter
Under the agreement, initial discussions will focus on developing new tests that could make the biggest impact to patient care.
Dave Hickey, senior vice president strategic planning and business development, Siemens Healthcare Diagnostics, said: “This agreement establishes a framework that gives both companies the opportunity to offer new diagnostic tests to laboratories, physicians and their patients more quickly and effectively than either could do alone. Advancing health care for patients is an important commitment that we can reach through strategic relationships such as this.”